Trials / Sponsors / Curon Biopharmaceutical (Australia) Co Pty Ltd
Curon Biopharmaceutical (Australia) Co Pty Ltd
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | A Study of CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancie Locally Advanced Solid Tumor, Metastatic Solid Tumor, Hematologic Malignancies | Phase 1 / Phase 2 | 2021-10-22 |
| Terminated | A Study of CN1 in Combination With CN401 in Adult Patients With Relapsed/Refractory Lymphoid Malignancies Relapsed Lymphoid Malignancies, Refractory Lymphoid Malignancies | Phase 1 / Phase 2 | 2021-07-28 |
| Completed | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CN1 Advanced Solid Tumor, B Cell Lymphoma | Phase 1 | 2020-07-02 |